Danaher (DHR) Amortization of Deferred Charges (2020 - 2024)
Danaher (DHR) posted quarterly Amortization of Deferred Charges of $25.0 million for Q1 2024, up 212.5% quarter-over-quarter from $8.0 million in Q4 2023.
Danaher (DHR) Amortization of Deferred Charges (2020 - 2024) Analysis & Trends
Danaher's Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $25.0 million for Q1 2024.
- In Q1 2024, Amortization of Deferred Charges changed N/A year-over-year to $25.0 million; the TTM figure through Dec 2024 stood at $25.0 million (up 212.5% YoY), while the FY2024 annual figure was $25.0 million, up 212.5% from the prior year.
- Amortization of Deferred Charges for Q1 2024 stood at $25.0 million, up from $8.0 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $39.8 million in Q4 2020, with the low at $8.0 million in Q4 2023.
- The 3-year median for Amortization of Deferred Charges is $25.0 million (2024), against an average of $24.3 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2024 | 25.00 Mn |
| Mar 29, 2024 | 25.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Dec 31, 2020 | 39.80 Mn |
| Dec 31, 2020 | 39.80 Mn |